Multiple Myeloma Rounds ®

Multiple Myeloma Rounds ®
           The Multiple Myeloma Rounds are Temporarily Going Virtual!
                                            A CHANGE OF PLANS
      During the last four years the Multiple Myeloma Rounds® has become a venerable source of continuing education by providing clinicians the opportunity to exchange information, network with their colleagues, share best practices, and learn the latest information on new therapies and advances in the management of multiple myeloma.
     In keeping with this spirit of clinical excellence, the Multiple Myeloma Rounds® National Committee has developed a response to address the current challenges presented by the COVID-19 social distancing protocols. To guarantee the safety of all the healthcare providers who participate in the Multiple Myeloma Rounds® activities and to uphold the integrity of the live-in person meetings, the committee has developed a live virtual format that will provide participants with a unique, interactive learning experience. We hope that you will register to participate in this live virtual meeting activity. We look forward to your participation in this program as well as a return to normalcy and meeting you all in-person for future activities.
To see if your city is hosting a live virtual program, click on the city tab above
                                             About the Multiple Myeloma Rounds®

In 2016, Dr. Agne Paner and her colleagues at several institutions in the Chicago area joined together to form the Chicago Multiple Myeloma Rounds Committee. Their collaborative effort led to the implementation of four Multiple Myeloma Rounds programs that were held in the Chicago area in 2016.

As a result of the success of the Chicago Multiple Myeloma Rounds, the Committee decided to expand the program to other multiple myeloma communities around the country.  

This program will continue to provide a forum for local healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their multiple myeloma patients.  

The Multiple Myeloma Rounds provides an opportunity for participants to exchange information, network with their colleagues, share best practices and learn the latest information on new therapies and advances in the management of multiple myeloma through interactive case studies presented by experts in the local area.

Please join us at one of the upcoming events! 

The Multiple Myeloma Rounds Program Chairs and Committee Members

Chicago Multiple Myeloma Rounds Founding Chair and CME Course Director: 
Agne Paner, MD Rush University

Chicago Multiple Myeloma Rounds Regional Chairpersons 
(A complete list of all Committee Members can be found on tab at top of page)
Ajay K. Nooka, MD, MPH, FACP Winship Cancer Institute Emory University
Agne Paner, MD Rush University
Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD Moffitt Cancer Center
 Ola Landgren, MD and Neha S. Korde, MD Memorial Sloan Kettering Cancer Center
William Bensinger, MD Swedish Cancer Institute and Edward Libby, MD Seattle Cancer Care Alliance 

 logo colors 04 text at bottomsmall12 252 LRF Final Logo
Plexus logo 1.28                        Rush Logo MasterBrndTransparent                                      


Accreditation Information: 

In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.


Rush University Medical Center designates this Live Activity for a maximum of two (2) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 


Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this live activity for two (2) Continuing Education credits. This activity provides 2.0 ONCC credit hours. This activity will fulfill Category 2 contact hour requirements for pharmacology for ANCC certified advanced practice nurses. 


This program is approved for 2.0 hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.

There is no fee for participating in this activity.

Educational Objectives:

1.  Distinguish among the biologic and molecular mechanisms involved in the pathology of MM as it relates to therapeutic targets and treatment selection

2.  Appraise conventional, newly approved, and emerging therapies thathave the potential to enhance clinical outcomes

3.  Identify disease- and therapy-associated adverse events and utilize evidence-based management strategies

4.  Devise optimal evidence-based strategies for individualized treatment

5. Identify limitations and controversies in the standard of care treatment in MM, and how these pertain to individual patient management


Date: August 4, 2020


6:00-6:45 pm- Introduction of Case #1: Targeting B-Cell Maturation Antigen (BCMA) in Multiple Myeloma

                        Presenter: Timothy Schmidt, MD 

                        Clinical Application of the BCMA Antibody-Drug Conjugate Belantamab Mafodotin in Multiple Myeloma

                         Presenter: Ajay K. Nooka, MD

                        AE profile of BCMA Antibody-Drug Conjugates

                         Presenter: Kathryn T. Maples PharmD, BCOP

                         Emory Workflow: Navigating Antibody-Drug Conjugates Through the Ophthal-oncology Departments

                          Presenter: Brittany N. Arwood , RN, MSN, CCRN

6:45-7:30 pm- Introduction of Case #2:  MRD in Myeloma: definition, logistics, and clinical implications

                        Ajay Nooka, MD

                        Winship Cancer Institute of Emory University

There will be opportunity for Q&A/Discussion during and after each of the presentations

Chicago Multiple Myeloma Rounds Committee 

Loyola University Medical Center: 
Kevin Barton, MD
      Patrick Hagen, MD

Advocate Lutheran General Hospital: 
Tulio Rodriguez, MD

Medical College of Wisconsin:
Binod Dhakal, MD
     Parameswaran Hari, MD

Rush University Medical Center:
Agne Paner, MD, (Program Chair) and Parameswaran Venugopal, MD

John H. Stroger, Jr Hospital of Cook County:
David Sumoza, MD    

University of Illinois at Chicago Medical Center:
    Pritesh Patel, MD

University of Chicago Medical Center:
Michael Bishop, MD


Date: August 11, 2020


(All times are in MDT)

5:00-5:45 pm- Introduction to Case #1: BiTE Molecules: A New Treatment in Relapsed Myeloma Population

                        Presented by: Henning Schade, MD

                       Colorado Blood Cancer Institute

5:45-6:30 pm - Introduction of Case #2: How to Optimize Therapy in Elderly/Frail Patients with Multiple Myeloma                    

                        Presented by: Dan Sherbenou, MD, PhD

                        University of Colorado Cancer Center



Date: August 5, 2020


(All times are PDT)

5:45pm-6:30 pm: Intro to Case #1: Post transplant maintenance versus intensification: Evidence

                              Presented by: Ann Mohrbacher, MD

                              Keck School of Medicine at USC

6:30pm-7:15 pm: Intro to Case #2: CAR-T Cell Therapy in Multiple Myeloma

                         Presented by: Sarah Larson, MD

                              UCLA Medical Center




Los Angeles Committee Members:

Robert Vescio, MD: Los Angeles Multiple Myeloma Rounds Chair: Medical Director, Cedars Sinai Medical Center

Amrita Krishnan, MD: City of Hope Cancer Center

Sarah Larson, MD:  Ronald Reagan UCLA Medical Center

Ann Mohrbacher, MD: Keck Medicine of USC

Seattle Multiple Myeloma Rounds Committee 

Swedish Cancer Institute
William Bensinger, MD (CO-CHAIR)
Seattle Cancer Care Alliance/University of Washington
      Edward Libby, MD (CO-CHAIR)
Fred Hutchinson Cancer Center: 
 Damian Green, MD

Swedish Cancer Institute: 
Ami Batchelder, PA-C
VA Puget Sound Health Care system/University of Washington Medical Center    
    Thomas Chauncey, MD

The Multiple Myeloma Rounds program is proudly endorsed by:
The Leukemia Foundation
The Amyloidosis Foundation

LRF Logo high res                                               logo colors 04 text at bottomsmall             

If your company is interested in exhibiting at any of these events, please contact us at:

E-mail: [email protected]

Phone: 1-866-607-4333

Your Information

Your Name*
Your Email:*
How did you hear about this program?: *

Categories: Regional Meetings / Symposia